France· FR:68852725
IMDYLLTRA 10 mg, poudre pour solution à diluer et solution pour solution pour perfusion
A tarlatamab product containing tarlatamab, registered in France by AMGEN EUROPE. The same ATC class is registered in 12 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Tarlatamab is registered in 12 of 19 countries.
Countries holding a registration under ATC L01FX33 (tarlatamab), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 7 of them publish a price we can compare per daily dose
Tarlatamab · ATC L01FX33
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TARLATAMAB
- Manufacturer
- AMGEN EUROPE
- Country
- France (FR)
- ATC code
- L01FX33
- ATC class
- Tarlatamab
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009551145981 flacon en verre de 10 mg de poudre + 2 flacons en verre de 7 mL de solution
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tarlatamab in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenIMDYLLTRA 1 mg Pulver till koncentrat och lösning till infusionsvätska, lösningAmgen Europe B.V.
- CanadaIMDELLTRAAMGEN CANADA INC
- SwitzerlandImdylltra 1 mg, Pulver für ein Konzentrat und Stabilisatorlösung zur Herstellung einer InfusionslösungAmgen Switzerland AG
- CzechiaIMDYLLTRAAmgen Europe B.V., Breda
- SpainIMDYLLTRA 1 MG POLVO PARA CONCENTRADO Y SOLUCIÓN PARA SOLUCION PARA PERFUSIONAmgen Europe B.V.
- FinlandImdylltraAmgen Europe B.V.
- BelgiumImdylltra 1 mgAmgen Europe
- United KingdomImdylltra 10mg powder for concentrate and solution for solution for infusion vialsAmgen Ltd
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Imdylltra
- Norway · Imdylltra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ce7c0574-4504-40cb-a8c2-96682a26b696 GET /v1/drugs/ce7c0574-4504-40cb-a8c2-96682a26b696?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68852725",
"date_amm": "2026-05-29",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/26/2033",
"substance": "TARLATAMAB",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre à diluer à diluer et solution pour solution pour solution",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about tarlatamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.